Into the Unknown: Advanced Concepts in Continuous Glucose Monitoring

Friday, March 22, 2024

9:15 AM – 10:15 AM East Coast USA Time

Location: Orange County Convention Center, W311AB

CE: 1.0

ACPE Number: 0202-0000-24-020-L01-P

Number of Hours: 1

Activity Type: Application

Speaker(s)

Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP (she/her/hers)

Endocrine Pharmacist
Cleveland Clinic
University Heights, Ohio, United States

Handout

Disclosure(s):

Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP: Abbott: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Ascensia: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Dexcom: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Eli Lilly: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Insulet: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Consultant (Ongoing); Novo Nordisk: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Sanofi: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Pharmacists are increasingly receiving questions related to continuous glucose monitoring (CGM) from patients. Attend this case-based discussion to dive into CGM metrics and guidelines, CGM reporting analysis, user error troubleshooting, and more.

This activity is sponsored by an independent educational grant from Abbott Diabetes Care.

Learning Objectives:

Discuss key continuous glucose monitoring metrics and time in range (TIR) guidelines for multiple types of people with diabetes.
Describe the DATAA model and how to use it to effectively analyze CGM data and facilitate shared decision making
Analyze CGM reports and provide clinical recommendations based on CGM data.